Kaleo Pharma

NEWS

Pictured: Doorway at the FTC building in Washingto

Policy

Three Companies Relent to FTC Demands, Delist Patents from FDA’s Orange Book

GSK withdrew three patents related to its asthma inhalers while Impax delisted both of its patents for Adrenaclick and Kaléo delisted eight patents covering Auvi-Q—the companies’ respective epinephrine auto-injectors.

December 22, 2023

2 min read

Kate Goodwin

BioCapital

Senators Question Kaleo Over 680% Price Hike of Naloxone Injector Evzio

February 10, 2017

1 min read

IN THE PRESS

Sanofi US To Return Auvi-Q (epinephrine injection, USP) Rights To Kaleo

February 24, 2016

5 min read

BioCapital

Kaleo Announces The Award Of Its 100th Patent

January 26, 2016

5 min read

BioCapital

More Than 600 Lives Reported Saved Since Launch Of The “kaleo Cares” EVZIO (naloxone HCl Injection) Auto-injector Donation Program

January 12, 2016

9 min read

BioCapital

Kaleo To Donate 50,000 EVZIO (naloxone Hcl Injection) Auto-Injectors In Honor Of The UNITE To Face Addiction Rally

September 30, 2015

10 min read

BioCapital

Kaleo Release: More than 100 Lives Reported Saved Since Launch Of The “kaleo Cares” EVZIO® (naloxone HCl injection) Donation Program

August 31, 2015

9 min read

BioCapital

Kaleo Supports Opioid Overdose Emergency Treatment Efforts With EVZIO™ (Naloxone Hcl Injection) Donations To Local Law Enforcement Agencies

October 29, 2014

8 min read

BioCapital

Kaleo Release: EVZIO™ (naloxone HCl injection) Auto-Injector Now Available In The United States For The Emergency Treatment Of Opioid Overdose

July 10, 2014

7 min read

Business

Kaleo Hires Tom Patterson As Chief Financial Officer

April 10, 2014

3 min read

BioCapital

Kaleo Announces $150 Million Debt Financing To Support Commercialization Of EVZIO™

April 7, 2014

7 min read

FDA

FDA Approves Kaleo’s Hand-Held Auto-Injector To Reverse Opioid Overdose

April 3, 2014

9 min read

JOBS